跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
C2 inhibitor
首页
药物
C2 inhibitor
C2 inhibitor
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of complement inhibitors to treat ocular diseases
US 8753625 B2
申请人: FUNG SEK CHUNG
优先权: 2005
CN
US
5 件公开
COMPOSITIONS AND METHODS FOR TREATING LUPUS NEPHRITIS
EP 4522216 A4
申请人: ANNEXON INC
优先权: 2022
CN
EP
US
WO
4 件公开
SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
EP 4228757 B1
申请人: SANOFI SA
优先权: 2020
EP
US
WO
4 件公开
EP 4228758 C0
申请人: SANOFI SA
优先权: 2020
EP
US
WO
4 件公开
METHOD OF DECREASING SEBUM PRODUCTION AND PORE SIZE
EP 1765272 B1
申请人: UNILEVER PLC
优先权: 2005
CN
EP
US
3 件公开
Pyrrole derivatives
US 2003181496 A1
申请人: TOKUNAGA TERUHISA
优先权: 2000
US
3 件公开
Tetracyclic derivatives, process of preparation and use
US 6369059 B1
申请人: ICOS CORP
优先权: 2000
US
3 件公开
PIPERIDINE/PIPERAZINE DERIVATIVES
US 2010210618 A1
申请人: BONGARTZ JEAN-PIERRE ANDRE MARC
优先权: 2007
US
3 件公开
US 8981094 B2
申请人: BONGARTZ JEAN-PIERRE ANDRÉ MARC
优先权: 2007
US
2 件公开
US 2010184776 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2007
US
MONO AND BIS-ESTER DERIVATIVES OF PYRIDINIUM AND QUINOLINIUM COMPOUNDS AS ENVIRONMENTALLY FRIENDLY CORROSION INHIBITORS
US 2008308770 A1
申请人: TIWARI LAXMIKANT
优先权: 2007
US
3 件公开
Macrophage activation inhibitor
US 2007142465 A1
申请人: UMEZAWA KAZUO
优先权: 2003
CN
US
2 件公开
T-TYPE CALCIUM CHANNEL INHIBITOR
US 2016096815 A1
申请人: UNIV KINKI
优先权: 2013
US
WO
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈